DNMT3B and plasma cell myeloma: Ai et al. (2019) showed that MDSCs maintain stemness by promoting piRNA-823 and DNMT3B activation in multiple myeloma cells and provide a novel target for MDSC and CSCs in multiple myeloma microenvironments [112].